the main
about the project
Medicine news
To authors
Licensed books on medicine
<< Ahead Next >>

RESTRICTIVE CARDIOMYOPATHY

<< Ahead Next >>
= Go to tutorial content =

RESTRICTIVE CARDIOMYOPATHY

  1. Restrictive cardiomyopathy.
    This is a primary or secondary myocardial disease, characterized by diastolic dysfunction, lack of dilatation or ventricular hypertrophy, the presence of increased systemic and pulmonary venous pressure. Restrictive cardiomyopathy occupies a special place among all myocardial diseases and is rare. ETIOLOGY. The cause of restrictive cardiomyopathy is considered fibroplastic
  2. Restrictive Cardiomyopathy
    Restrictive CMP is associated with a decrease in the extensibility of the ventricular walls with manifestations of signs of hypodiastolia and symptoms of congestion in the major and minor circulation. Primary myocardial (isolated myocardial damage, similar to DCM). Endomyocardial (endocardial thickening and infiltrative necrotic and infiltrative changes in the myocardium). 1. Hyper-eosinophilic
  3. RESTRICTIVE CARDIOMYOPATHY.
    According to the WHO experts, two diseases are attributed to restrictive cardiomyopathy: endomyocardial fibrosis and Löffler endo-carditis. There is a term that combines both diseases - "Endomyocardial disease". Diseases are found in countries with a hot climate. Endemic foci have been identified in Uganda, Tanzania, Zambia, Mozambique,
  4. Restrictive Cardiomyopathy
    Restrictive cardiomyopathy (RCMP) is a rare myocardial disease with frequent involvement of the endocardium, which is characterized by impaired filling of one or both ventricles with a decrease in their diastolic volume with an unchanged wall thickness. Due to the deterioration of the diastolic properties of the ventricle, after a short period of rapid filling, further blood flow into it is practically
  5. Restrictive cardiomyopathy
    Restrictive cardiomyopathy (RCMP) is known in two versions of Fanee, considered as two distinct pathological processes) - endocardial fibrosis and endomyocardial fibroelastosis * eFflera. The pathomorphological picture in two diseases differs little and is characterized by a sharp thickening of the endocardium in combination with ventricular myocardial hypertrophy, the cavities of which
  6. Primary idiopathic restrictive cardiomyopathy
    A rare form of non-infiltrative myocardial disease with restrictive-type diastolic dysfunction. The absence of LVH and systolic dysfunction is characteristic. Often inherited and associated with skeletal myopathy. The disease usually occurs sporadically, but may be inherited in an autosomal dominant manner. The occurrence of a rigid ventricle may be due to pathology.
  7. Cardiomyopathy. Hypertrophic cardiomyopathy (code 142.0)
    The term "cardiomyopathy" refers to a state of unknown etiology, the most important signs of which are cardiomegaly and heart failure; this name excludes heart disease resulting from valve damage, impaired coronary blood flow, hypertension of the large and small circulation. Etiology. Clinical and anatomical forms. Prospective
  8. Restrictive lung diseases
    Causes of restrictive lung disease Causes of acute restrictive disease: • ????? pulmonary edema; • ???? ARDS; •????aspiration; • ???? neurogenic edema; • ????? opioid overdose; • ???? congestive myocardial insufficiency; • ???? pleural effusion; •????pneumothorax; • ???? increase mediastinum; • ???? pneumomediastinum. Chronic lung disease leading to restrictive
  9. Restrictive lung diseases
    Restrictive diseases are characterized by a decrease in lung compliance. Lung volumes are below normal, while the volumetric flow rate on the exhalation is not reduced. Thus, FEV1 and FZHEL are reduced, but the value of the OFVch / FZHEL ratio remains normal. Restrictive diseases include many acute and chronic pathological conditions of the lungs, as well as lesions of the pleura, chest wall, diaphragm and
  10. Obstructive and restrictive lung diseases
    There are two types of diffuse lung lesions. These are obstructive processes, affecting mainly the airways and characterized by an increase in resistance to the passage of air due to partial or complete obstruction at any level (from the trachea to the respiratory bronchioles), and restrictive processes that are associated with a decreased expansion of the lung parenchyma during inhalation and
Medical portal "MedguideBook" © 2014-2016
info@medicine-guidebook.com